Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate – serotonin interactions for pharmacotherapy

Summary. Based on 1) neuroanatomical and neuroimaging studies indicating aberrations in brain regions that are rich in glutamate neurons and 2) similarities between symptoms produced by N-methyl-D-aspartate (NMDA) antagonists in healthy subjects and those seen in autism, it is proposed in the present paper that infantile autism is a hypoglutamatergic disorder. Possible future pharmacological interventions in autism are discussed in the light of the intimate interplay between central glutamate and serotonin, notably the serotonin (5-HT) 2A receptor. The possible benefit of treatment with glutamate agonists [e.g. agents acting on the modulatory glycine site of the NMDA receptor, or so-called ampakines acting on the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor] is discussed, as well as the potential usefulness of a selective 5-HT2A receptor antagonist.

[1]  M. Katz,et al.  Characterizing the psychological state produced by LSD. , 1968, Journal of abnormal psychology.

[2]  R. Barry,et al.  Coding of stimulus parameters in autistic, retarded, and normal children: evidence for a two-factor theory of autism. , 1988, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[3]  B. Leventhal,et al.  The serotonin system in autism. , 1996, Current opinion in pediatrics.

[4]  Y. Samson,et al.  Delayed maturation of the frontal cortex in childhood autism. , 1995, The American journal of psychiatry.

[5]  Hugh Jolly,et al.  Clinics in Developmental Medicine , 1965 .

[6]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[7]  A R Damasio,et al.  A neurological model for childhood autism. , 1978, Archives of neurology.

[8]  K. Lees,et al.  Clinical experience with excitatory amino acid antagonist drugs. , 1995, Stroke.

[9]  Temple Grandin,et al.  An Inside View of Autism , 1992 .

[10]  R. Lydiard.  Obsessive‐compulsive disorder: a new perspective in diagnosis and treatment , 1994, International clinical psychopharmacology.

[11]  C. McDougle,et al.  A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. , 1996, Archives of general psychiatry.

[12]  G. Aghajanian,et al.  Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. , 1994, European journal of pharmacology.

[13]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[14]  O. Sacks,et al.  An anthropologist on Mars , 1994 .

[15]  J. Krystal,et al.  Psychopharmacology: The Third Generation of Progress , 1989, The Yale Journal of Biology and Medicine.

[16]  R. Heath,et al.  Phencyclidine: An Overview , 1977 .

[17]  L. Schreibman,et al.  Selective responding by autistic children to multiple sensory input. , 1971, Journal of abnormal psychology.

[18]  E. Ornitz,et al.  Perceptual inconstancy in early infantile autism. The syndrome of early infant autism and its variants including certain cases of childhood schizophrenia. , 1968, Archives of general psychiatry.

[19]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[20]  Myung Cw,et al.  Drug addiction and drug abuse in Korea. , 1974 .

[21]  D. Javitt,et al.  Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia , 1996, British Journal of Psychiatry.

[22]  E. Courchesne.  Neuroanatomic imaging in autism. , 1991, Pediatrics.

[23]  J. Kootz.  Modulation of sensory intake in autistic children , 1981 .

[24]  P. Muglia,et al.  Clinical effects of clozapine on autistic disorder. , 1996, The American journal of psychiatry.

[25]  L. Schreibman,et al.  Stimulus overselectivity of autistic children in a two stimulus situation. , 1971, Behaviour research and therapy.

[26]  E. Ornitz,et al.  Disorders of perception common to early infantile autism and schizophrenia. , 1969, Comprehensive psychiatry.

[27]  I. Cohen,et al.  A comparison of haloperidol and behavior therapy and their interaction in autistic children. , 1978, Journal of the American Academy of Child Psychiatry.

[28]  H. Chugani,et al.  Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography , 1996, Annals of neurology.

[29]  Parashos Aj.  The psilocybin-induced "state of drunkenness" in normal volunteers and schizophrenics. , 1976 .

[30]  A. Reiss,et al.  The Mesial‐temporal Lobe and Autism: Case Report and Review , 1992 .

[31]  A. Labelle,et al.  Risperidone in the Treatment of Pervasive Developmental Disorder , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[32]  R. Baker,et al.  Obsessions, Compulsions, Clozapine, and Risperidone , 1997, CNS Spectrums.

[33]  L. Wing,et al.  Asperger's syndrome: a clinical account , 1981, Psychological Medicine.

[34]  T. Kemper,et al.  Hippocampus in autism: a Golgi analysis , 1995, Acta Neuropathologica.

[35]  I. Rapin,et al.  Autistic children: diagnosis and clinical features. , 1991, Pediatrics.

[36]  N J Cox,et al.  Evidence of linkage between the serotonin transporter and autistic disorder , 1997, Molecular Psychiatry.

[37]  E Courchesne,et al.  Parietal lobe abnormalities detected with MR in patients with infantile autism. , 1993, AJR. American journal of roentgenology.

[38]  Christopher Gillberg,et al.  The biology of the autistic syndromes, 2nd ed. , 1992 .

[39]  F. Vollenweider,et al.  Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis , 1997, Neuropsychopharmacology.

[40]  N. Minshew.  Indices of neural function in autism: clinical and biologic implications. , 1991, Pediatrics.

[41]  C. Gillberg,et al.  Autism and related behaviours. , 2008, Journal of intellectual disability research : JIDR.

[42]  C. Gillberg,et al.  The epidemiology of Asperger syndrome. A total population study. , 1993, Journal of child psychology and psychiatry, and allied disciplines.

[43]  U. Brand,et al.  Effects of chronic amphetamine treatment on the glutamate concentration in cerebrospinal fluid and brain: Implications for a theory of schizophrenia , 1981, Neuroscience Letters.

[44]  C. McDougle,et al.  Risperidone in Adults with Autism or Pervasive Developmental Disorder , 1995 .

[45]  D. Milman.  An untoward reaction to accidental ingestion of LSD in a 5-year-old girl. , 1967, Journal of the American Medical Association (JAMA).

[46]  M. Millan,et al.  Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors. , 1995, European journal of pharmacology.

[47]  T. Hilden,et al.  The psychotropic effect of ketamine. , 1988, Journal of psychoactive drugs.

[48]  T. Kemper,et al.  Histoanatomic observations of the brain in early infantile autism , 1985, Neurology.

[49]  J. Deveaugh-Geiss.  Pharmacologic therapy of obsessive compulsive disorder. , 1994, Advances in pharmacology.

[50]  A. McDonald,et al.  Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: Colocalization of excitatory amino acids and projections to the limbic circuit , 1996, The Journal of comparative neurology.

[51]  L. Kanner.  Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.

[52]  T. Byrne,et al.  Case study: anorexia nervosa and autistic disorder in an adolescent girl. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[53]  A. Carlsson,et al.  Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone , 1998, Journal of Neural Transmission.

[54]  M. Bauman,et al.  Microscopic neuroanatomic abnormalities in autism. , 1991, Pediatrics.

[55]  G. A. Ladee.  [Use and abuse of LSD]. , 1968, Nederlands tijdschrift voor geneeskunde.

[56]  K. L. Leenders,et al.  Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) , 1997, European Neuropsychopharmacology.